Associations between chronic kidney disease and age-related macular degeneration

Dorothea Nitsch1, Jennifer Evans, Paul J Roderick

  • 1Department of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London, UK. Dorothea.Nitsch@lshtm.ac.uk

Insights

Proteinuria, a marker of kidney disease, is linked to age-related macular degeneration (AMD) in men but not women. This suggests sex-specific risk factors for AMD in older adults.

Area of Science:

  • Ophthalmology
  • Nephrology
  • Geriatrics

Background:

  • Age-related macular degeneration (AMD) and chronic kidney disease (CKD) share cardiovascular risk factors and complement pathway alterations.
  • Limited research exists on the association between AMD and CKD.

Purpose of the Study:

  • To investigate the association between markers of renal impairment and AMD in an older population.
  • To explore potential sex differences in the relationship between renal function and AMD.

Main Methods:

  • A population-based cross-sectional study compared individuals aged 75+ with AMD (n=516) to those with normal vision (n=2755).
  • Estimated glomerular filtration rate (eGFR) and proteinuria were assessed using established formulas and dipstick tests.
  • Statistical analyses adjusted for various confounding factors, including sex.

Main Results:

  • Proteinuria showed a positive association with AMD in men (OR 2.06) but not in women (OR 0.62) after adjustments.
  • Reduced eGFR (<45 ml/min/1.73 m²) was associated with AMD in men, but this link disappeared after accounting for proteinuria.
  • Significant interactions by sex were observed for both proteinuria and eGFR associations with AMD (p<0.05).

Conclusions:

  • Proteinuria may be a significant risk factor for AMD specifically in men.
  • The differing associations by sex suggest potential biological or measurement-related differences in how kidney function impacts AMD.
  • Further research is needed to clarify the mechanisms and confirm findings, especially regarding proteinuria detection in women.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...